WNT9A and prostate carcinoma: WNT7B, WNT9A and WNT10B did indeed cause a small increase in LNCaP cell growth and motility, and WNT7B has been shown to be required for the growth of both androgen-dependent and castration-resistant prostate cancer cells in other studies [26].